Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42582 |
RATIO-LACTULOSE | 667MG/ML | BOTTLE | Resolved | 2017-03-14 | 2017-12-15 | 2400 |
RATIO-LACTULOSE | 667MG | SOLUTION | Resolved | 2024-05-03 | 2024-09-19 | 226933 |
TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3118 |
TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2017-03-15 | 2017-12-15 | 2986 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3121 |
RATIO-METFORMIN | 850MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5168 |
RATIO-METFORMIN | 850MG | TABLET | Resolved | 2019-09-05 | 2020-07-10 | 93162 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2017-11-16 | 2018-01-04 | 29441 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
TEVA-NYSTATIN | 100000UNIT | DROPS | Resolved | 2017-03-14 | 2018-03-08 | 2410 |
RATIO-NYSTATIN | 100000UNIT | OINTMENT | Resolved | 2017-03-17 | 2017-09-05 | 3145 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-17 | 2017-04-25 | 3148 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-05-11 | 2975 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-05-11 | 2978 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-02-22 | 2983 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |